We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Immunoassay Assessed for Diagnosis of Norovirus Gastroenteritis

By LabMedica International staff writers
Posted on 14 Mar 2012
The sensitivity and specificity of a commercial Norovirus immunochromatographic test has been evaluated on human stool samples. More...


The immunochromatographic test is based on reverse transcription-polymerase chain reaction (RT-PCR) and the sensitive RT-nested PCR and was compared with another commercial real-time RT-PCR for detection of Norovirus in stool samples.

Scientists at Mahidol University (Bangkok, Thailand) tested 86 stool samples for noroviruses using the commercial immunochromatographic test RIDA QUICK Norovirus, which uses the biotin-streptavidin-peroxidase method. In addition, 54 Norovirus-positive samples from a second test group were also detected, and the copy number of Norovirus quantified by using a commercial real-time RT-PCR. Norovirus GI and GII antigens in stool samples can be detected using the RIDA QUICK Norovirus Test.

The sensitivity was analyzed using stool samples of the two test groups, which were confirmed for Norovirus infection by RT-PCR and RT-nested PCR, respectively. Based on the RT-PCR, the sensitivity of the RIDAQUICK Norovirus assay (R-Biopharm; Darmstadt, Germany) was 83.3% (15/18 samples), but compared with the RT-nested PCR, the sensitivity decreased to 48.2% (26/54 samples). The specificity of the assay was analyzed using Norovirus-negative stool samples from the control group and accounted for 87.5% (28/32 samples). The assay revealed false positives of 12.5%.

Among 23 stool samples showing Norovirus positive by both the RIDA QUICK Norovirus assay and the real-time RT-PCR (Shanghai ZJ Bio-Tech, Shanghai, China), the virus could be detected in samples taken on days 1–8 after onset of illness and these samples harbored Norovirus GII. The real-time RT-PCR for the simultaneous detection of Norovirus GI and GII and quantitation was completed on the LightCycler 1.5 Instrument Real Time PCR System (Roche Diagnostics, Mannheim, Germany). Viral ribonucleic acid (RNA) was extracted using the QIAam Viral RNA extraction kit (QIAGEN GmbH, Hilden, Germany).

The authors concluded that the RIDA QUICK Norovirus assay is rapid and simple to perform. The assay has high sensitivity and specificity. This method is appropriate to use for early diagnosis of acute gastroenteritis caused by noroviruses and for rapid screening of Norovirus infections in patients with acute gastroenteritis in both developed and developing countries where the RT-PCR method has not been established for routine diagnosis. However, negative results where Norovirus is strongly suspected should be further tested by more sensitive molecular techniques.

The study was published online on February 23, 2012, in the European Journal of Clinical Microbiology & Infectious Diseases.

Related Links:
Mahidol University
R-Biopharm
Roche Diagnostics




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.